|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of goods sold | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Distribution, selling, and administrative | |||||
| Depreciation | |||||
| Amortization | |||||
| Litigation and opioid-related expenses (credit), net | |||||
| Acquisition, integration, and restructuring expenses | |||||
| Acquisition-related deal and integration expenses | |||||
| Restructuring and other expenses | |||||
| Asset impairment | |||||
| Operating income | |||||
| Other loss (income), net | |||||
| Interest expense, net | |||||
| Income before income taxes | |||||
| Income tax expense | |||||
| Net income | |||||
| Net (income) loss attributable to noncontrolling interests | |||||
| Net income attributable to Cencora, Inc. | |||||
| Earnings per share: | |||||
| Basic (in usd per share) | |||||
| Diluted (in usd per share) | |||||
| Weighted average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...